Srivastava Madhur Kumar, Pagala Ram Manohar, Kendarla Vinodh, Nallapareddy Kavitha
Department of Nuclear Medicine, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India.
World J Nucl Med. 2020 Sep 14;20(3):281-285. doi: 10.4103/wjnm.WJNM_77_20. eCollection 2021 Jul-Sep.
Myocardial perfusion imaging (MPI) is an important investigative tool in the diagnosis and management of coronary artery disease. This investigation has seen a manifold increase in number in past decades as compared to other investigations such as cardiac magnetic resonance imaging/positron emission tomography or computed tomography. In 2005, "Appropriate use criteria (AUC) in cardiac radionuclide imaging" was formulated by the American College of Cardiology Foundation and the American Society of Nuclear Cardiology for effective use of this investigation, later revised in 2009. We assessed the appropriateness of indications for MPI in patients presenting to the nuclear medicine department of a tertiary care hospital according to the latest AUC for cardiac radionuclide imaging. This is a retrospective analysis of all cardiac perfusion scans performed from June 2019 to January 2020 in a tertiary care teaching hospital in South India. All patients' indications for MPI were assessed for appropriateness using AUC 2009 as appropriate, inappropriate, and uncertain indications by two experienced nuclear medicine physicians blinded for results of the test and hospital stay of the patients. A total of 1015 cardiac scans were performed in the given period, which were analyzed. This included 613 males and 402 females, with most of the patients aged above 60 years ( = 640; males = 385, females = 255). Most of the patients had diabetes mellitus or hypertension or both except in 161 patients (15.8%) which did not have either of the comorbidities. Chest pain and/or shortness of breath were the most common presenting complaints. The appropriate indication for imaging was found in 784 patients (77.2%), inappropriate in 121 patients (12%), and uncertain in 110 patients (10.8%). Our results showed appropriate indication to be 77.2% and inappropriate indications as 12% for MPI referrals in a tertiary care teaching hospital, similar to Western literature but can be improved further by continued teaching and awareness campaigns.
心肌灌注成像(MPI)是冠状动脉疾病诊断和管理中的一项重要检查工具。与其他检查如心脏磁共振成像/正电子发射断层扫描或计算机断层扫描相比,在过去几十年中,这项检查的数量呈多倍增长。2005年,美国心脏病学会基金会和美国核心脏病学会制定了“心脏放射性核素成像的合理使用标准(AUC)”,以有效利用这项检查,该标准于2009年进行了修订。我们根据最新的心脏放射性核素成像AUC,评估了一家三级护理医院核医学科就诊患者MPI检查指征的合理性。这是对2019年6月至2020年1月在印度南部一家三级护理教学医院进行的所有心脏灌注扫描的回顾性分析。由两名对检查结果和患者住院情况不知情的经验丰富的核医学医生,根据AUC 2009将所有患者的MPI检查指征评估为合理、不合理和不确定指征。在给定期间共进行了1015次心脏扫描并进行了分析。其中包括613名男性和402名女性,大多数患者年龄在60岁以上(n = 640;男性 = 385,女性 = 255)。除161名患者(15.8%)没有任何一种合并症外,大多数患者患有糖尿病或高血压或两者兼有。胸痛和/或呼吸急促是最常见的就诊主诉。784名患者(77.2%)的成像指征合理,121名患者(12%)不合理,110名患者(10.8%)不确定。我们的结果显示,在一家三级护理教学医院,MPI转诊的合理指征为77.2%,不合理指征为12%,与西方文献相似,但通过持续的教学和宣传活动可以进一步改善。